Stock Track | Hims & Hers Health Soars 5% as Momentum Continues Following Earnings Beat and Analyst Upgrade

Stock Track05-07

Shares of Hims & Hers Health Inc. (HIMS) are soaring 5.01% in Wednesday's trading session, continuing the strong momentum from Tuesday's 18% surge following the company's impressive first-quarter earnings report.

The telehealth company's stock received an additional boost as Deutsche Bank raised its target price to $43 from $38, reflecting increased confidence in the company's growth prospects. This analyst upgrade comes on the heels of Hims & Hers' better-than-expected financial results, which have reignited investor interest in the stock.

The positive sentiment is further evidenced by heightened options activity, with 696,070 contracts traded on Tuesday, representing a 79% increase from the previous trading day. Notably, call options accounted for 61% of the overall options trades, indicating bullish expectations among investors. The surge in both stock price and options volume suggests that market participants are increasingly optimistic about Hims & Hers Health's future performance in the telehealth sector.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

1

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1186017407?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-07 22:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186017407","market":"sg","top_or_hot":-1,"title":"Stock Track | Hims & Hers Health Soars 5% as Momentum Continues Following Earnings Beat and Analyst Upgrade","media":"Stock Track","content":"<p>Shares of Hims & Hers Health Inc. (HIMS) are soaring 5.01% in Wednesday's trading session, continuing the strong momentum from Tuesday's 18% surge following the company's impressive first-quarter earnings report.</p>\n\n<p>The telehealth company's stock received an additional boost as Deutsche Bank raised its target price to $43 from $38, reflecting increased confidence in the company's growth prospects. This analyst upgrade comes on the heels of Hims & Hers' better-than-expected financial results, which have reignited investor interest in the stock.</p>\n\n<p>The positive sentiment is further evidenced by heightened options activity, with 696,070 contracts traded on Tuesday, representing a 79% increase from the previous trading day. Notably, call options accounted for 61% of the overall options trades, indicating bullish expectations among investors. The surge in both stock price and options volume suggests that market participants are increasingly optimistic about Hims & Hers Health's future performance in the telehealth sector.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Hims & Hers Health Soars 5% as Momentum Continues Following Earnings Beat and Analyst Upgrade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Hims & Hers Health Soars 5% as Momentum Continues Following Earnings Beat and Analyst Upgrade\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-07 22:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Hims & Hers Health Inc. (HIMS) are soaring 5.01% in Wednesday's trading session, continuing the strong momentum from Tuesday's 18% surge following the company's impressive first-quarter earnings report.</p>\n\n<p>The telehealth company's stock received an additional boost as Deutsche Bank raised its target price to $43 from $38, reflecting increased confidence in the company's growth prospects. This analyst upgrade comes on the heels of Hims & Hers' better-than-expected financial results, which have reignited investor interest in the stock.</p>\n\n<p>The positive sentiment is further evidenced by heightened options activity, with 696,070 contracts traded on Tuesday, representing a 79% increase from the previous trading day. Notably, call options accounted for 61% of the overall options trades, indicating bullish expectations among investors. The surge in both stock price and options volume suggests that market participants are increasingly optimistic about Hims & Hers Health's future performance in the telehealth sector.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMS","symbol_name":"Hims & Hers Health Inc.","start_time":0,"source_url":"","article_id":"1186017407","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186017407","pubTimestamp":1746628528,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Hims & Hers Health Inc.  are soaring 5.01% in Wednesday's trading session, continuing the strong momentum from Tuesday's 18% surge following the company's impressive first-quarter earnings report.The telehealth company's stock received an additional boost as Deutsche Bank raised its target price to $43 from $38, reflecting increased confidence in the company's growth prospects. This analyst upgrade comes on the heels of Hims & Hers' better-than-expected financial results, which have re","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"translate_title":"股票跟踪Hims&Hers Health飙升5%，盈利超出预期和分析师升级后势头持续","themeId":"b6b4a3ee9e2c91645c4cd3ec55cbf5ad","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":1},"content_text":"Shares of Hims & Hers Health Inc. (HIMS) are soaring 5.01% in Wednesday's trading session, continuing the strong momentum from Tuesday's 18% surge following the company's impressive first-quarter earnings report.\nThe telehealth company's stock received an additional boost as Deutsche Bank raised its target price to $43 from $38, reflecting increased confidence in the company's growth prospects. This analyst upgrade comes on the heels of Hims & Hers' better-than-expected financial results, which have reignited investor interest in the stock.\nThe positive sentiment is further evidenced by heightened options activity, with 696,070 contracts traded on Tuesday, representing a 79% increase from the previous trading day. Notably, call options accounted for 61% of the overall options trades, indicating bullish expectations among investors. The surge in both stock price and options volume suggests that market participants are increasingly optimistic about Hims & Hers Health's future performance in the telehealth sector.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1186017407","isCrawlerRequest":true}